Accessibility Menu
Ak Medical logo

Ak Medical(SEHK) 1789

Market CapHK$5.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+110%
5 Year-38%
1 Year-9%
1 Month-7%
HK$5.06
-0.78%
-0.04Today
Ak Medical last closing stock price
MetricPriceDate
Last closeHKD 5.102026-08-31
Ak Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.41%HKD 5.892026-08-24
1 month-7.44%HKD 5.512026-07-31
3 month-13.27%HKD 5.882026-06-02
Year to date-10.53%HKD 5.702025-12-31
1 year-8.93%HKD 5.602025-08-29
3 year-19.3%HKD 6.322023-08-31
5 year-37.58%HKD 8.172021-09-01
Since inception+109.77%HKD 2.432017-12-20

Ak Medical Financials at a Glance

Market Cap

HK$5.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥2.93B

Net Income (TTM)

CN¥667.77M

EPS (TTM)

HK$0.38

P/E Ratio

13.56

Dividend

HK$0.12

Beta (Volatility)

-0.06 (Low)

Price

HK$5.06

Volume

630,000

Open

HK$5.14

Previous Close

HK$5.10

Daily Range

HK$5.06 - HK$5.16

52-Week Range

HK$4.75 - HK$7.15

Estimated Earnings Date

Mar 31, 2027

1789 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ak Medical

AK Medical Holdings Limited is a leading enterprise specializing in the research, development, production, and global commercialization of orthopedic joint implants and related medical devices. Established in 2003 in Beijing, the company offers a diverse range of products, including conventional and advanced 3D-printed orthopedic solutions.

Products and Services
  • Conventional knee, hip, and spine replacement implants
  • Advanced 3D-printed solutions like hip implants and spinal interbody cages
  • Distribution of third-party orthopedic products and surgical instruments
Growth Outlook
  • Revenue increased to CNY 788 million in Q4 2025, up from CNY 694 million in Q2 2025
  • Net income rose to CNY 178 million in Q4 2025, reflecting strong operational performance
  • Continued investment in R&D to enhance product offerings and market reach
Financial Highlights
  • Trailing twelve-month revenue of CNY 2.8 billion, showcasing consistent growth
  • Net profit margin of 22.87% in Q4 2025, indicating effective cost management
  • Strong cash flow with operating cash flow of CNY 226 million in Q4 2025
AK Medical Holdings Limited operates in the medical devices sector, focusing on orthopedic solutions. The company has demonstrated robust financial performance, with a significant increase in revenue and net income in recent quarters. The strong net profit margin indicates effective cost management and operational efficiency. With a commitment to research and development, AK Medical is well-positioned to expand its product offerings and market presence, making it an attractive option for potential investors. The company's solid cash flow further supports its growth initiatives and operational stability.
AI Generated • Aug 7, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

983

CEO

Zhi Jiang Li, MBA

Website

www.ak-medical.net

Headquarters

Beijing, BE 102299, CN

1789 Financials

Key Financial Metrics (TTM)

Gross Margin

62.75%

Operating Margin

27.09%

Net Income Margin

24.15%

Return on Equity

13.14%

Return on Capital

12.22%

Return on Assets

10.52%

Earnings Yield

7.37%

Dividend Yield

2.31%

Payout Ratio

19.44%

Stock Overview

Market Cap

HK$5.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.12B

Volume

630.00K

Avg. Volume

4.97M

Financials (TTM)

Gross Profit

CN¥1.79B

Operating Income

CN¥733.27M

EBITDA

CN¥839.12M

Operating Cash Flow

CN¥896.30M

Capital Expenditure

-CN¥265.11M

Free Cash Flow

CN¥631.19M

Cash & ST Invst.

CN¥1.25B

Total Debt

CN¥78.25M

Ak Medical Performance Analysis

Ak Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 1,223,402,51933.3%
20232023-12-31CNY 1,208,715,319-1.2%
20242024-12-31CNY 1,459,774,04420.8%
20252025-12-31CNY 1,607,739,74110.1%
Ak Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-314.1%
Q22025-06-300.7%
Q42025-12-3113.5%
Q22026-06-30-4.3%
Ak Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.21114.0%
20232023-12-31CNY 0.18-15.6%
20242024-12-31CNY 0.2747.7%
20252025-12-31CNY 0.3323.7%
Ak Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-7.7%
Q22025-06-3016.7%
Q42025-12-3114.3%
Q22026-06-306.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥754.17M

+13.9%

Gross Profit

CN¥480.71M

+19.7%

Gross Margin

63.74%

N/A

Market Cap

HK$5.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$5.83M

N/A

Employees

981

N/A

Net Income

CN¥194.00M

+39.3%

EBITDA

CN¥211.10M

+8.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥1.25B

+65.1%

Total Debt

CN¥78.25M

-13.9%

Accounts Receivable

CN¥781.36M

+15.0%

Inventory

CN¥470.29M

-21.5%

Long Term Debt

CN¥8.50M

-81.7%

Short Term Debt

CN¥69.75M

+57.4%

Return on Assets

10.52%

N/A

Return on Invested Capital

14.78%

N/A

Free Cash Flow

CN¥196.78M

+484.9%

Operating Cash Flow

CN¥226.76M

+1058.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 1789

What is the current price of Ak Medical?

Ak Medical is trading at HK$5.06 per share.

What is the 52-week range for Ak Medical?

Over the past 52 weeks, Ak Medical has traded between HK$4.75 and HK$7.15.

How much debt does Ak Medical have?

As of the most recent reporting period, Ak Medical reported total debt of CN¥161.20M.

How much cash does Ak Medical have on hand?

Ak Medical reported CN¥684.07M in cash and cash equivalents in its most recent financial results.

What is Ak Medical’s dividend yield?

Ak Medical currently has a dividend yield of 2.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services